HKU Scholars Hub: Browsing DSpace

Browsing by Author Chao, G

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 16 of 16

	Title	Author(s)	Issue Date
	A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B Journal:Gastroenterology	Lai, CL Leung, N Teo, EK Tong, M Wong, F Hann, HW Han, S Poynard, T Myers, M Chao, G Lloyd, D Brown, NA	2005
	Effect of core promoter/precore mutation pattern and early virologic response on efficacy outcomes with telbivudine in HBeAg-negative chronic hepatitis B Proceeding/Conference:Journal of Hepatology	Naoumov, N Lai, CL Gane, E Liaw, YF Thongsawat, S Wang, YM Heathcote, EJ Rasenack, J Bzowej, N Chao, G Brown, N	2006
	Final results of a phase I/II dose escalation trial of valtorcitabine in patients with chronic hepatitis B Proceeding/Conference:Journal of Hepatology	Lim, SG Lai, CL Myers, M Yuen, RMF Wai, CT Lloyd, D Pietropalolo, K Zhou, XJ Chao, G Brown, NA	2005
	HBV resistance determination from the telbivudine globe registration trial Proceeding/Conference:Journal of Hepatology	Standring, DN Seifer, N Patty, A Chapron, C Van Doorn, LJ Chao, G Brown, N Lai, CL	2006
	Maximal Early Hbv Suppression In Nucleoside-treated Hepatitis B Patients Is Associated With Optimal Virologic And Clinical Efficacy At One Year Journal:Journal of Clinical Virology	Lim, SG Lai, CL Thongsawat, S Wang, Y Chen, Y Rasenack, J Naoumov, N Chao, G Brown, N	2006
	Maximal early HBV suppression is predictive of optimal virologic and clinical efficacy in nucleoside-treated hepatitis B patients: scientific observations from a large multinational trial (the GLOBE study) Proceeding/Conference:Hepatology	Lai, CL Gane, E Liaw, YF Thongsawat, S Wang, YM Chen, Y Heathcote, J Rasenack, J Bzowej, N Naoumov, N Chao, G Fielman, B Brown, N the GLOBE Study Group	2005
	Optimal virologic and clinical efficacy at one year is associated with maximal early HBV suppression in nucleoside-treated hepatitis B patients Proceeding/Conference:Journal of Hepatology	Zeuzem, S Lai, CL Gane, E Liaw, YF Thongsawat, S Wang, YM Chen, Y Heathcote, J Rasenack, J Bzowej, N Naoumov, N Chao, G Fielman, B Brown, N	2006
	Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year Proceeding/Conference:Journal of Hepatology	Gane, E Lai, CL Liaw, YF Thongsawat, S Wang, YM Cheng, Y Heathcote, J Rasenack, J Bzowej, N Naoumov, N Chao, G Fielman, B Brown, N	2006
	Phase III Comparison of Telbivudine vs Lamivudine in Patients with Chronic Hepatitis B: Efficacy, Safety, and Predictors of Response at 1 Year Proceeding/Conference:Gastroenterology	Bzowej, N Lai, CL Gane, E Liaw, Y Thongsawat, S Wang, Y Chen, Y Heathcote, J Rasenack, J Naoumov, N Chao, G Fielman, B Brown, N	2006
	A Randomized Trial of Telbivudine (LdT) vs Adefovir for HBeAg-positive Chronic Hepatitis B: Results of the Primary Week 24 Analysis Proceeding/Conference:Gastroenterology	Heathcote, EJ Chan, HL Cho, M Lai, CL Moon, YM Chao, YC Myers, R Minuk, G Marcellin, P Jeffers, L Sievert, W Kaiser, R Chao, G Brown, N	2006
	A randomized trial of telbivudine (LDT) vs. adefovir for HBeAg-positive chronic hepatitis B: Results of the primary week 24 analysis Proceeding/Conference:Journal of Hepatology	Chan, HLY Lai, CL Cho, M Heathcote, J Moon, Y-M Chao, Y-C Myers, R Minuk, G Marcellin, P Jeffers, L Sievert, W Kaiser, R Chao, G Brown, N	2006
	Results of a One-year International Phase IIB Comparative Trial of Telbivudine, Lamivudine, and the Combination, in Patients with Chronic Hepatitis B Proceeding/Conference:Hepatology	Lai, CL Leung, NWY Teo, EK Tong, M Wong, F Hann, HW Han, S Poynard, T Myers, M Chao, G Lloyd, D Brown, N	2003
	Telbivudine (LdT) vs. lmivudine for chronic Hepatitis B: First-year results from the international phase III GLOBE trial Proceeding/Conference:Hepatology	Lai, CL Gane, E Liaw, YF Thongsawat, S Wang, YM Chen, Y Heathcote, J Rasenack, J Bzowej, N Naoumov, N Chao, G Fielman, B Brown, N and the GLOBE Study Group, .	2005
	Telbivudine displays consistent antiviral efficacy across patient subgroups for the treatment of chronic hepatitis B: Results from the GLOBE study Proceeding/Conference:Journal of Hepatology	Thongsawat, S Lai, CL Gane, E Chao, G Fielman, B Brown, N GLOBE Investigator Group, .	2006
	Telbivudine versus lamivudine in patients with chronic hepatitis B Journal:New England Journal of Medicine	Lai, CL Gane, E Liaw, YF Hsu, CW Thongsawat, S Wang, Y Chen, Y Heathcote, EJ Rasenack, J Bzowej, N Naoumov, NV Di Bisceglie, AM Zeuzem, S Moon, YM Goodman, Z Chao, G Constance, BF Brown, NA	2007
	Valtorcitabine provides potent suppression of hepatitis B virus in patients with chronic hepatitis B: Results of a phase I/II clinical trial Proceeding/Conference:Hepatology	Lai, CL Brown, NA Yuen, RMF Wai, CT Lloyd, D Pietropaolo, K Zhou, XJ Chao, G Lim, SG	2004

Showing results 1 to 16 of 16